I’ve recently started recommending Vitamin D supplementation after several articles and non-published research starting showing increasing evidence on the role of Vitamin D and the immune system. The world at large began scrambling for things to treat COVID-19. While the world was gathering new treatments, some of us began to look at what we knew to be tried and true remedies. Until recently, we have learned the critical importance of Vitamin D and the role that it plays for Covid. I, myself, have begun taking weekly high dose Vitamin D injections because of recently finding out that I was Vitamin D deficient. Even Dr. Fauci recently stated that he takes high dose of Vitamin D since the pandemic and as an effective measure for the virus. In the past two months, there has been a great body of work in Europe (more aggressive with this virus than our country) has shown success with Vitamin C and Vitamin D in high doses. So, why haven’t we started recommending it? Probably because it works. I’m a scientist and I know how slow the wheels of progress works when it comes to any treatment for any condition.
Here’s what you should know. Most elderly, sick, and African Americans suffer from Vitamin D Deficiency. For decades, African Americans weren’t even tested for Vitamin D Deficiency because we were told that Melanin in our skin protected us from being Vitamin D Deficient. WRONG! Vitamin D plays an essential role and now that we are in the winter months we are not getting enough Vitamin D. Also, the pills that you take. Well, not so good. But, we don’t have a lot of options unless you take it in injectables. I argue two points all day that Vitamin B and Vitamin D is best utilized by the body if you inject. The pills form does not supply what you need because it does not bypass the GI tract where most of the acids in the stomach destroy the absorption of the vitamin. So for effective prevention and treatment, consider vitamin supplementation through injectables and IV drips. If you are worried about a little prick, consider the deadly effects of this virus. Below I have cited a recent study on Vitamin D.
COvid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): study protocol for a randomized controlled trial
Trials volume 21, Article number: 1031 (2020)
With the lack of effective therapy, chemoprevention, and vaccination against SARS-CoV-2, focusing on the immediate repurposing of existing drugs gives hope of curbing the COVID-19 pandemic. A recent unbiased genomics-guided tracing of the SARS-CoV-2 targets in human cells identified vitamin D among the three top-scoring molecules manifesting potential infection mitigation patterns. Growing pre-clinical and epidemiological observational data support this assumption. We hypothesized that vitamin D supplementation may improve the prognosis of COVID-19. The aim of this trial is to compare the effect of a single oral high dose of cholecalciferol versus a single oral standard dose on all-cause 14-day mortality rate in COVID-19 older adults at higher risk of worsening.
The COVIT-TRIAL study is an open-label, multicenter, randomized controlled superiority trial. Patients aged ≥ 65 years with COVID-19 (diagnosed within the preceding 3 days with RT-PCR and/or chest CT scan) and at least one worsening risk factor at the time of inclusion (i.e., age ≥ 75 years, or SpO2 ≤ 94% in room air, or PaO2/FiO2 ≤ 300 mmHg), having no contraindications to vitamin D supplementation, and having received no vitamin D supplementation > 800 IU/day during the preceding month are recruited. Participants are randomized either to high-dose cholecalciferol (two 200,000 IU drinking vials at once on the day of inclusion) or to standard-dose cholecalciferol (one 50,000 IU drinking vial on the day of inclusion). Two hundred sixty participants are recruited and followed up for 28 days. The primary outcome measure is all-cause mortality within 14 days of inclusion. Secondary outcomes are the score changes on the World Health Organization Ordinal Scale for Clinical Improvement (OSCI) scale for COVID-19, and the between-group comparison of safety. These outcomes are assessed at baseline, day 14, and day 28, together with the serum concentrations of 25(OH)D, creatinine, calcium, and albumin at baseline and day 7.
COVIT-TRIAL is to our knowledge the first randomized controlled trial testing the effect of vitamin D supplementation on the prognosis of COVID-19 in high-risk older patients. High-dose vitamin D supplementation may be an effective, well-tolerated, and easily and immediately accessible treatment for COVID-19, the incidence of which increases dramatically and for which there are currently no scientifically validated treatments